Relative to its peers, OGEN does not have very much institutional sponsorship. The 12.85% of shares outstanding held by institutional investors is among the least of any stock in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 3.4 Thousand shares of Oragenics Inc
RBC DOMINION SECURITIES, INC. Bought 125.00 shares of Oragenics Inc
MORGAN STANLEY SMITH BARNEY LLC Sold 8.00 shares of Oragenics Inc